The FDA is condemning children to death by refusing to allow them access to experimental cancer treatments, even though it has the authority to grant such access to terminal patients who have not responded to conventional treatment. Six years ago, 10-year-old Braiden was enrolled in a clinical trial for his incurable brain tumor. The “experimental” drug Antineoplaston (ANP) was the sole treating agent. He went into full remission, and suffered no toxic side effects. An MRI recently revealed Braiden’s tumor has reoccurred. The FDA is now refusing to allow Braiden to go back on ANP even though the treatment has already proven its efficacy through his previous remission. Many other terminal patients are also being prevented from accessing ANP.
You can’t live without this vitamin. But the FDA wants to reserve the natural form for monopoly drug companies, leaving only the synthetic form for supplements. The FDA has just released a new 109-page guidance on the revision of nutrition and supplement labels. On page 69, the agency slipped in two little paragraphs that could risk the health of millions of people who desperately need folate. It’s a sneak attack so quiet and unobtrusive that few people will even realize it’s there.
Jim Crawford started New Morning Farm in Maryland many decades ago. He was young and idealistic. He had little or no money and had to start small. He believed in sustainable agriculture and wanted to produce fresh and healthy produce to sell in farmers’ markets to the urban public. He succeeded and became increasingly well known both for his ideals and his produce. This may be why the FDA picked him out for a site visit. An inspector appeared without warning and told him that his operation would have to change. It didn't matter that no health problem had ever been associated with Crawford’s impeccably run operation. The Food Safety Modernization Act for the first time gave the FDA direct authority over our farms. It should have been obvious to everyone that putting the FDA in direct charge of farms was a terrible idea. Much of the FDA’s budget is paid for by Big Pharma instead of the taxpayers, which creates a serious conflict of interest.
A meeting at the FDA on experiments to create GMO humans has brought disturbing information to light. Yesterday and today (Feb. 25-26) the US Food and Drug Administration held public meetings outlining the creation of genetically modified humans. These experiments won’t take place in the distant future. In fact, GMO embryos have already been created via in vitro experiments. While the FDA has stated that the agency “recognizes” that there are “ethical and social policy issues” to be considered—and despite the fact that forty-four countries have already banned this kind of genetic manipulation—the FDA won’t bother to discuss **if** human clinical trials should take place (that’s considered to be “outside the scope” of the meeting). Instead, they’ll outline **how** such trials should be conducted.
The US Food and Drug Administration (FDA) has known for more than 12 years that routine use of antibiotics in livestock is harmful to human health, yet it has taken no meaningful action. Routine use of antibiotics in food animals has promoted a rapid rise in antibiotic-resistant disease, which now claims more lives than emphysema, HIV/AIDS, Parkinson’s disease, and homicide combined. Two million American adults and children become infected with antibiotic-resistant bacteria each year, and at least 23,000 of them die as a direct result of those infections. Virtually all animal feed additives containing penicillin and tetracycline antibiotics—both of which are used to treat human disease—pose a “high risk” to human health, according to a new report. Many bacteria are developing cross resistance; a situation where a bacteria becomes resistant to multiple drugs, making them virtually impossible to eradicate once they infect you.
FDA Violates Patient Privacy Laws: Provides Patient Records to USA Today to Attack Cancer Doctor Burzynski
We have covered the history of the government's relentless attacks against cancer doctor Stanislaw Burzynski, M.D., Ph.D. His story has also been documented in an award winning film, and you can watch one of the trailers here. Dr. Burzynski has cured many people of cancer without FDA approved drugs, which is a direct threat to the largest pharmaceutical business in the world today: Cancer Treatment. The Alliance for Natural Health brings us the latest updates on how the FDA is still attacking this doctor in Houston, by using the mainstream media, specifically USA Today. In the process, they have violated their own laws regarding patient privacy in their effort to attack Dr. Burzynski, who has been successful in treating cancer without FDA approved drugs.
Ractopamine is banned from food production in at least 160 countries around the world, including countries across Europe, Russia, mainland China and Republic of China (Taiwan), due to its suspected health effects. Since 1998, more than 1,700 people have reportedly been “poisoned” from eating pigs fed the drug. If imported meat is found to contain traces of the drug, it is turned away, while fines and imprisonment result for its use in banned countries. While Americans are largely unaware that the drug is even used, many other nations seem to be far better informed. Fear that the ractopamine ban might be lifted brought thousands of demonstrators onto the streets in Taiwan last year, demanding that the ban remain in place. In February of this year, Russia issued a ban on US meat imports, warning it would remain in place until the US agrees to certify that the meat is ractopamine-free. As reported by Pravda, Russia is the fourth largest importer of US meats, purchasing about $500 million-worth of beef and pork annually. At present, the US does not even test for the presence of this drug in meats sold.
Diabetes drug Avandia was linked to significantly increased risks of heart attack and cardiovascular death, prompting the FDA to restrict access to the drug in 2010. Europe banned Avandia, taking it completely off the market. The FDA has now announced it is lifting those restrictions to allow widespread access to the drug once again. The decision was based on a heavily criticized study conducted by the drug’s maker, GlaxoSmithKline (which pleaded guilty to fraud in 2012 for failing to report safety problems with Avandia).
There’s still a small window to make the FDA listen to reason. “Medical foods,” by the federal government’s definition, aren't simply a diet plan prescribed by a doctor. They are foods that are specifically formulated and processed for a sick patient and are intended to meet specific nutritional requirements for the management of a disease or condition. The FDA has recently issued an updated draft guidance that drastically limits the number of conditions that medical foods can be used to manage. Under the new guidance, producers of medical foods will either have to reformulate their products to go through the drug approval process (which can cost billions of dollars) or market them as dietary supplements (which would severely limit the claims their products could make, depriving practitioners and consumers of valuable health information). By making the “buy-in” for the medical industry affordable only to Big Pharma, small businesses and start-up innovators will be kicked out of the industry, drug companies will reap the rewards of yet another FDA-sponsored monopoly, and consumers will be left to deal with the ramifications of limited, more expensive options.
There’s a reason your government is whittling away at your healthcare options and driving costs out of control—and not a good one. America spends over $2.6 trillion a year (18% of our GDP) on healthcare. At the same time, government is tightening the regulatory reins on nutritional and natural methods to support health—an approach that isn’t lowering healthcare spending, but raising it! On November 22, the FDA sent a warning letter to 23andMe.com to stop its inexpensive ($99 per test) “do-it-yourself” genetic testing service for health screening and ancestry purposes, because consumers could be “misled” and harm themselves by “self-treating.” The FDA’s stance on DIY genetic testing could very well drive up healthcare costs. Besides premiums being raised on those forced to report DNA results to insurance companies, in-office testing is far more expensive. As tests are priced anywhere from $300 to $3,500, this could significantly add to the overall cost of healthcare. The FDA’s true message is clear: because individuals can’t be trusted to make sound health decisions, they don’t have a right to private information on their own DNA.